Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown (Q39452760)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown |
scientific article |
Statements
1 reference
Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown (English)
1 reference
Sara Previdi
1 reference
Giovanni Abbadessa
1 reference
Francesca Dalò
1 reference
Dennis S France
1 reference
25 October 2011
1 reference
1 reference
Identifiers
1 reference